Key facts
- KluraLabs’s last known valuation is $28.0M (Mar 2023).
- It has raised $16.6M; the latest was Later Stage VC ($10.5M) in Feb 2026.
- Notable investors include Innovate UK, SFC Capital, London & Partners., Winklevoss Capital Management, Accelerate Cambridge — 15 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 15 names
- ·Watchlist + deal alerts for KluraLabs
- ·The full record, as it builds
Funding rounds
No funding rounds for KluraLabs are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About KluraLabs
Operator of a materials science research and development company intended to keep surfaces sanitized. The company uses surface-functionalized nanostructures to inactivate viruses on the spot and have antimicrobial and antifungal properties, enabling clients to reduce the spread of coronavirus and other viral infections.
- Sector
- Materials and Resources
- HQ
- Haverhill, United Kingdom
- Founded
- 2020
- Employees
- 25
- Website
- klura.com/
- Ownership
- Privately Held (backing)
KluraLabs doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in KluraLabs shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on KluraLabs in its N-PORT filings yet. We sweep new filings monthly.